Insider sale
TAYSHA GENE THERAPIES, INC.
$56.3K
19.60K shares
What this filing means
MCGINNIS EMILY plans to sell 19.60K shares of TAYSHA GENE THERAPIES, INC. valued at approximately $56.3K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 8/21/2025ACC: 0001415889-25-022687
19.60K
Shares to sell
$56.3K
Approx. market value
19.60K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
RSU Award
Vested grant settled instock; consideration was Reporting Person's continued service as an employee ofthe Issuer.
8/21/2025
19.60KTotal acquired19.60K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
8/21/2025 | RSU Award Vested grant settled instock; consideration was Reporting Person's continued service as an employee ofthe Issuer. | 19.60K | — |
| Total | 19.60K | ||
Planned & Completed Dispositions1
NasdaqPlanned
Units to sell
19.60K
Market value
$56.3K
8/21/2025
Total
Units
19.60K
Value
$56.3K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
8/21/2025 | 19.60K | $56.3K | Nasdaq | Planned |
| Total | 19.60K | $56.3K | ||